other material
confidence high
sentiment neutral
materiality 0.15
Shareholders approve issuance of up to 20.46M shares in Deerfield convertible notes and warrants
Oncology Institute, Inc.
- All nine director nominees elected with strong support; broker non-votes of ~12.2M shares.
- Ratification of BDO USA as independent auditor approved: 60.8M for, 192k against, 50k abstain.
- Proposal 3 approved: allows issuance of up to 20,459,040 shares upon conversion of Deerfield convertible notes and exercise of warrants.
- Turnout: 61.08M shares voted (82.06% of outstanding).